Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Allegro designs and develops breakthrough biomedical nanotechnology for the treatment of osteo arthritis.
Antwerp, Région flamande, Belgium
Send a message
Anglais
Anglais
Allegro designs and develops novel biomedical nanotechnology hydrogel for the treatment of osteo arthritis, through a revolutionary mode of action.
Osteo Arthritis is a chronic, degenerative disease that causes cartilage damage and inflammation. It affects more than 10% of the entire global population, who experience pain, inability to sport, reduced mobility and face serious surgery.
We introduce a novel therapy which:
- Directly restores the...
Allegro designs and develops novel biomedical nanotechnology hydrogel for the treatment of osteo arthritis, through a revolutionary mode of action.
Osteo Arthritis is a chronic, degenerative disease that causes cartilage damage and inflammation. It affects more than 10% of the entire global population, who experience pain, inability to sport, reduced mobility and face serious surgery.
We introduce a novel therapy which:
- Directly restores the mechanical visco-elastic properties of the joint fluid and
- Stops the progress of the disease (inflammation and cartilage degenaration)
This is possible thanks to our nano biopolymer technology that features unique properties:
- 4,5x stronger than best alternative
- 300x more shock absorbing potential than best alternative
- Recovery potential (smart material)
The product has been validated, showing:
- Safe to use (biocompatibility)
- Efficacy: fully tested on mice and horses, with unprecedented good clinical results.
4
Followers
2
Like